Overview

Evaluation of Lovastatin in Severe Persistent Asthma

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study has two purposes: 1. to determine whether lovastatin, a commonly used medication to lower cholesterol in the blood, can produce beneficial changes in airway inflammation and in the airway smooth muscle 2. to examine whether lovastatin will have favorable changes in asthma symptoms of patients with moderate or severe asthma.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Chicago
Treatments:
Dihydromevinolin
L 647318
Lovastatin